Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Advanced Breast Cancer × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Platinum-Refractory Fallopian Tube Carcinoma 2 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma, Ovarian 1 Teratoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Recurrent Bladder Urothelial Carcinoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Inflammatory Breast Neoplasms 1

Interventions

eribulin 1 balixafortide 1 Taxes 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡